Article info
PDFOriginal research
Predictive value of the new ESGO-ESTRO-ESP endometrial cancer risk classification on survival and recurrence in the Danish population
- Correspondence to Dr Gitte Ortoft, Department of Gynecology, Copenhagen University Hospital, 2100 Copenhagen, Denmark; ortoft{at}dadlnet.dk
Citation
Predictive value of the new ESGO-ESTRO-ESP endometrial cancer risk classification on survival and recurrence in the Danish population
Publication history
- Received March 1, 2021
- Accepted May 28, 2021
- First published June 10, 2021.
Article Versions
- You are currently viewing a Previous version of this article (8 January 2022).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.